vs
Organogenesis Holdings Inc.(ORGO)与WSFS FINANCIAL CORP(WSFS)财务数据对比。点击上方公司名可切换其他公司
WSFS FINANCIAL CORP的季度营收约是Organogenesis Holdings Inc.的7.4倍($275.3M vs $37.2M),WSFS FINANCIAL CORP同比增速更快(7.5% vs -57.1%),过去两年WSFS FINANCIAL CORP的营收复合增速更高(1.7% vs -46.5%)
Organogenesis Holdings Inc.是一家领先的再生医学企业,专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品,主要服务美国及部分国际市场的医疗机构与患者,提供经临床验证的医疗解决方案。
WSFS金融集团是一家金融服务企业,核心子公司WSFS银行是总部位于特拉华州及大特拉华谷地区规模最大、经营历史最久的本地管理银行与财富管理机构。集团共运营115个网点,其中88个为银行网点,分布在宾夕法尼亚、特拉华、新泽西、佛罗里达、弗吉尼亚、内华达六州,提供全面金融服务。
ORGO vs WSFS — 直观对比
营收规模更大
WSFS
是对方的7.4倍
$37.2M
营收增速更快
WSFS
高出64.6%
-57.1%
两年增速更快
WSFS
近两年复合增速
-46.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $37.2M | $275.3M |
| 净利润 | — | $86.8M |
| 毛利率 | 30.8% | — |
| 营业利润率 | -185.1% | — |
| 净利率 | — | 31.5% |
| 营收同比 | -57.1% | 7.5% |
| 净利润同比 | — | 31.7% |
| 每股收益(稀释后) | — | $1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ORGO
WSFS
| Q1 26 | $37.2M | $275.3M | ||
| Q4 25 | $225.6M | $271.9M | ||
| Q3 25 | $150.9M | $270.5M | ||
| Q2 25 | $101.0M | $267.5M | ||
| Q1 25 | $86.7M | $256.1M | ||
| Q4 24 | $126.7M | $261.5M | ||
| Q3 24 | $115.2M | $267.7M | ||
| Q2 24 | $130.2M | $266.0M |
净利润
ORGO
WSFS
| Q1 26 | — | $86.8M | ||
| Q4 25 | $43.7M | $72.7M | ||
| Q3 25 | $21.6M | $76.4M | ||
| Q2 25 | $-9.4M | $72.3M | ||
| Q1 25 | $-18.8M | $65.9M | ||
| Q4 24 | $7.7M | $64.2M | ||
| Q3 24 | $12.3M | $64.4M | ||
| Q2 24 | $-17.0M | $69.3M |
毛利率
ORGO
WSFS
| Q1 26 | 30.8% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 72.6% | — | ||
| Q4 24 | 75.5% | — | ||
| Q3 24 | 76.7% | — | ||
| Q2 24 | 77.6% | — |
营业利润率
ORGO
WSFS
| Q1 26 | -185.1% | — | ||
| Q4 25 | 28.1% | 35.8% | ||
| Q3 25 | 13.7% | 37.3% | ||
| Q2 25 | -12.5% | 35.7% | ||
| Q1 25 | -30.9% | 34.0% | ||
| Q4 24 | 8.1% | 32.3% | ||
| Q3 24 | 5.4% | 31.9% | ||
| Q2 24 | -10.7% | 34.0% |
净利率
ORGO
WSFS
| Q1 26 | — | 31.5% | ||
| Q4 25 | 19.4% | 26.7% | ||
| Q3 25 | 14.3% | 28.3% | ||
| Q2 25 | -9.3% | 27.0% | ||
| Q1 25 | -21.7% | 25.7% | ||
| Q4 24 | 6.1% | 24.6% | ||
| Q3 24 | 10.7% | 24.1% | ||
| Q2 24 | -13.1% | 26.0% |
每股收益(稀释后)
ORGO
WSFS
| Q1 26 | — | $1.64 | ||
| Q4 25 | $0.31 | $1.33 | ||
| Q3 25 | $0.11 | $1.37 | ||
| Q2 25 | $-0.10 | $1.27 | ||
| Q1 25 | $-0.17 | $1.12 | ||
| Q4 24 | $0.05 | $1.08 | ||
| Q3 24 | $0.09 | $1.08 | ||
| Q2 24 | $-0.13 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $91.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $2.7B |
| 总资产 | $520.0M | $22.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ORGO
WSFS
| Q1 26 | $91.4M | — | ||
| Q4 25 | $93.7M | $1.7B | ||
| Q3 25 | $63.7M | — | ||
| Q2 25 | $73.1M | — | ||
| Q1 25 | $110.0M | — | ||
| Q4 24 | $135.6M | $1.2B | ||
| Q3 24 | $94.3M | — | ||
| Q2 24 | $89.9M | — |
总债务
ORGO
WSFS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $62.3M | — | ||
| Q2 24 | $63.8M | — |
股东权益
ORGO
WSFS
| Q1 26 | — | $2.7B | ||
| Q4 25 | $300.1M | $2.7B | ||
| Q3 25 | $255.1M | $2.8B | ||
| Q2 25 | $233.2M | $2.7B | ||
| Q1 25 | $242.9M | $2.7B | ||
| Q4 24 | $262.9M | $2.6B | ||
| Q3 24 | $278.5M | $2.7B | ||
| Q2 24 | $263.5M | $2.5B |
总资产
ORGO
WSFS
| Q1 26 | $520.0M | $22.1B | ||
| Q4 25 | $598.7M | $21.3B | ||
| Q3 25 | $509.8M | $20.8B | ||
| Q2 25 | $461.1M | $20.8B | ||
| Q1 25 | $467.4M | $20.5B | ||
| Q4 24 | $497.9M | $20.8B | ||
| Q3 24 | $446.3M | $20.9B | ||
| Q2 24 | $443.2M | $20.7B |
负债/权益比
ORGO
WSFS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图